Literature DB >> 29392623

Effect of aerobic and resistance training on inflammatory markers in heart failure patients: systematic review and meta-analysis.

M J Pearson1, S F Mungovan2,3, N A Smart4.   

Abstract

Elevated levels of pro-inflammatory markers are evident in patients with heart failure and are associated with disease severity and prognosis. Exercise training has been shown to reduce circulating levels of pro-inflammatory cytokines and other pro-inflammatory markers in healthy and clinical populations. The aim of the systematic review and meta-analysis was to investigate the effect of aerobic (AT) and resistance training (RT) interventions on circulating concentrations of inflammatory markers; tumour necrosis factor-alpha (TNF-α), interleukin 6 (IL-6), C-reactive protein (CRP), fibrinogen, soluble intercellular adhesion molecule (sICAM) and soluble vascular adhesion molecule (sVCAM) in heart failure patients. We conducted database searches (PubMed, EMBASE and Cochrane Trials Register to 30 June 2017) for exercise-based trials in heart failure, using the following search terms: exercise training, inflammation, tumour necrosis factor-alpha, interleukin 6, C-reactive protein, fibrinogen, soluble intercellular adhesions molecule-1, soluble vascular adhesion molecule-1. Twenty studies, representing 18 independent trials, were included in the review. Pooled data of six studies indicated a minimally favourable effect of exercise training on circulating TNF-α [SMD 0.42 (95% CI 0.15, 0.68), p = 0.002)]. However, together the pooled and descriptive analyses failed to provide strong evidence for a reduction in other pro-inflammatory markers. However, given the complexity of heart failure and the pathways involved in the immune and inflammatory process, large prospective trials considering aetiology, comorbidities and local skeletal muscle inflammation are required to elucidate on the anti-inflammatory effect of exercise in this population.

Entities:  

Keywords:  CRP; Fibrinogen; Heart failure; IL-6; Inflammatory markers; TNF-α; sICAM-1; sVCAM-1

Mesh:

Substances:

Year:  2018        PMID: 29392623     DOI: 10.1007/s10741-018-9677-0

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


  71 in total

Review 1.  Systemic inflammation in heart failure--the whys and wherefores.

Authors:  Arne Yndestad; Jan Kristian Damås; Erik Oie; Thor Ueland; Lars Gullestad; Pål Aukrust
Journal:  Heart Fail Rev       Date:  2006-03       Impact factor: 4.214

2.  Bias in meta-analysis detected by a simple, graphical test.

Authors:  M Egger; G Davey Smith; M Schneider; C Minder
Journal:  BMJ       Date:  1997-09-13

3.  Elevated circulating levels of tumor necrosis factor in severe chronic heart failure.

Authors:  B Levine; J Kalman; L Mayer; H M Fillit; M Packer
Journal:  N Engl J Med       Date:  1990-07-26       Impact factor: 91.245

Review 4.  Fibrinogen as a key regulator of inflammation in disease.

Authors:  Dimitrios Davalos; Katerina Akassoglou
Journal:  Semin Immunopathol       Date:  2011-10-31       Impact factor: 9.623

5.  Study of insulin resistance, TNF-α, total antioxidant capacity and lipid profile in patients with chronic heart failure under exercise.

Authors:  Konstantinos Tsarouhas; Christina Tsitsimpikou; Alexander Haliassos; Panagiotis Georgoulias; Ioannis Koutsioras; Demetrios Kouretas; John Kogias; Ioannis Liosis; Elias Rentoukas; Zenon Kyriakides
Journal:  In Vivo       Date:  2011 Nov-Dec       Impact factor: 2.155

Review 6.  Effects of Statin Treatment on Inflammation and Cardiac Function in Heart Failure: An Adjusted Indirect Comparison Meta-Analysis of Randomized Trials.

Authors:  Kwadwo Osei Bonsu; Daniel Diamond Reidpath; Amudha Kadirvelu
Journal:  Cardiovasc Ther       Date:  2015-12       Impact factor: 3.023

7.  Effect of Caloric Restriction or Aerobic Exercise Training on Peak Oxygen Consumption and Quality of Life in Obese Older Patients With Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial.

Authors:  Dalane W Kitzman; Peter Brubaker; Timothy Morgan; Mark Haykowsky; Gregory Hundley; William E Kraus; Joel Eggebeen; Barbara J Nicklas
Journal:  JAMA       Date:  2016-01-05       Impact factor: 56.272

8.  Combined endurance/resistance training reduces plasma TNF-alpha receptor levels in patients with chronic heart failure and coronary artery disease.

Authors:  V M Conraads; P Beckers; J Bosmans; L S De Clerck; W J Stevens; C J Vrints; D L Brutsaert
Journal:  Eur Heart J       Date:  2002-12       Impact factor: 29.983

9.  Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: a randomized study.

Authors:  Ulrik Wisløff; Asbjørn Støylen; Jan P Loennechen; Morten Bruvold; Øivind Rognmo; Per Magnus Haram; Arnt Erik Tjønna; Jan Helgerud; Stig A Slørdahl; Sang Jun Lee; Vibeke Videm; Anja Bye; Godfrey L Smith; Sonia M Najjar; Øyvind Ellingsen; Terje Skjaerpe
Journal:  Circulation       Date:  2007-06-04       Impact factor: 29.690

10.  Multiplex cytokine concentration measurement: how much do the medium and handling matter?

Authors:  Luke Parkitny; James H McAuley; Patrick J Kelly; Flavia Di Pietro; Barbara Cameron; G Lorimer Moseley
Journal:  Mediators Inflamm       Date:  2013-09-28       Impact factor: 4.711

View more
  10 in total

1.  Therapeutic Efficacy of Aerobic Exercise Training along with Oak Husk Hydroalcoholic Extract for Amelioration of Inflammation in Obese Elderly Male Mice.

Authors:  Iman Zakavi; Shila Nayebifar; Elham Ghasemi; Aliasghar Valipour
Journal:  Biomed Res Int       Date:  2021-05-03       Impact factor: 3.411

Review 2.  Exercise Training Protocols to Improve Obesity, Glucose Homeostasis, and Subclinical Inflammation.

Authors:  Tiego A Diniz; Barbara M Antunes; Jonathan P Little; Fabio S Lira; José Cesar Rosa-Neto
Journal:  Methods Mol Biol       Date:  2022

3.  Construction and analysis of the lncRNA‑miRNA‑mRNA network based on competitive endogenous RNA reveals functional genes in heart failure.

Authors:  Guohong Wang; Xianghui Zheng; Yang Zheng; Rui Cao; Maomao Zhang; Yong Sun; Jian Wu
Journal:  Mol Med Rep       Date:  2018-12-10       Impact factor: 2.952

4.  Targeting the DPP-4-GLP-1 pathway improves exercise tolerance in heart failure patients: a systematic review and meta-analysis.

Authors:  Chengcong Chen; Ying Huang; Yongmei Zeng; Xiyan Lu; Guoqing Dong
Journal:  BMC Cardiovasc Disord       Date:  2019-12-23       Impact factor: 2.298

5.  High Intensity Interval Training Leads to Similar Inflammatory Activation as Seen With Traditional Training in Chronic Heart Failure.

Authors:  Arlana G Taylor; Andrew I Ignaszewski; Shannon S D Bredin; John S Hill; Erin M Shellington; Darren E R Warburton
Journal:  Front Cardiovasc Med       Date:  2022-02-08

6.  Subcutaneous adipose tissue sclerostin is reduced and Wnt signaling is enhanced following 4-weeks of sprint interval training in young men with obesity.

Authors:  Nigel Kurgan; Hashim Islam; Jennifer B L Matusiak; Bradley J Baranowski; Joshua Stoikos; Val A Fajardo; Rebecca E K MacPherson; Brendon J Gurd; Panagiota Klentrou
Journal:  Physiol Rep       Date:  2022-03

7.  Plasma-derived exosomes implement miR-126-associated regulation of cytokines secretion in PBMCs of CHF patients in vitro.

Authors:  Larysa Natrus; Dmytro Labudzynskyi; Petro Muzychenko; Petro Chernovol; Yuliia Klys
Journal:  Acta Biomed       Date:  2022-07-01

Review 8.  Unveiling the role of exercise training in targeting the inflammatory paradigm of heart failure with preserved ejection fraction: a narrative review.

Authors:  Eliane Jaconiano; Daniel Moreira-Gonçalves
Journal:  Heart Fail Rev       Date:  2021-07-10       Impact factor: 4.214

Review 9.  Muscle Wasting and Sarcopenia in Heart Failure-The Current State of Science.

Authors:  Alessia Lena; Markus S Anker; Jochen Springer
Journal:  Int J Mol Sci       Date:  2020-09-08       Impact factor: 5.923

10.  MicroRNA-27b-3p down-regulates FGF1 and aggravates pathological cardiac remodelling.

Authors:  Guoqi Li; Yihui Shao; Hong Chang Guo; Ying Zhi; Bokang Qiao; Ke Ma; Jie Du; Yong Qiang Lai; Yulin Li
Journal:  Cardiovasc Res       Date:  2022-07-20       Impact factor: 13.081

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.